Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,320 shares at $211.22 ($1.8M) on 2021-02-11, disclosed to the SEC on 2021-02-16.
Seasonal sale ($1.8M) by EVP, Chief Patient Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $210.43 | 3,860 | $812K | 46.4% |
| 2 | $210.43 | 3,860 | $812K | 46.4% |
| 3 | $211.22 | 500 | $106K | 6.0% |
| 4 | $211.98 | 100 | $21K | 1.2% |
| Total | $210.50 avg | 8,320 | $1.8M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |